Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer.
Ma L, Hernandez MO, Zhao Y, Mehta M, Tran B, Kelly M, Rae Z, Hernandez JM, Davis JL, Martin SP, Kleiner DE, Hewitt SM, Ylaya K, Wood BJ, Greten TF, Wang XW.
Cancer Cell. 2019 Oct 14;36(4):418-430.e6. doi: 10.1016/j.ccell.2019.08.007. Epub 2019 Oct 3.
PMID:31588021
TRENDS AND ALTERNATIVES IN TREATMENT OF MALIGNANT TUMORS OF EXTRAHEPATIC BILE DUCTS.
Stoyanov V, Dimitrova V.
Khirurgiia (Sofiia). 2015;81(3):149-60.
PMID:26887062
[Cholangiocarcinomas].
Schöning W, Haber PK, Pratschke J.
Chirurgie (Heidelb). 2025 Jan;96(1):77-86. doi: 10.1007/s00104-024-02200-z. Epub 2024 Dec 10.
PMID:39658583
[Cholangiocarcinoma].
Burgos San Juan L.
Rev Med Chil. 2008 Feb;136(2):240-8. Epub 2008 May 7.
PMID:18483680
Prevention of major biliary complications by fusion imaging for thermal ablation of malignant liver tumors adjacent to the bile ducts: a preliminary comparative study.
Carcinoid tumors of the extrahepatic bile ducts: a study of seven cases.
Maitra A, Krueger JE, Tascilar M, Offerhaus GJ, Angeles-Angeles A, Klimstra DS, Hruban RH, Albores-Saavedra J.
Am J Surg Pathol. 2000 Nov;24(11):1501-10. doi: 10.1097/00000478-200011000-00005.
PMID:11075851
From the archives of the AFIP. Benign tumors and tumorlike lesions of the gallbladder and extrahepatic bile ducts: radiologic-pathologic correlation. Armed Forces Institute of Pathology.